Chikungunya Virus Mutant (A226V) E1 Antigen, Recombinant

Ref. 3D-CL6250

Informations sur le produit

• Nom: Chikungunya Virus Mutant (A226V) E1 Antigen, Recombinant
• Marque: Biosynth
• Description: Transmitted by mosquito vectors, Chikungunya is a positive-stranded RNA, alpha virus infecting human musculoskeletal tissues. The glycoproteins E1 and E2 of the Chikungunya virus, are responsible for viral entry into host cells and both contain a transmembrane domain. Furthermore E2 has the three globular domains A, B and C which are linked by a β-ribbon connector region. While E2 is essential for mediating viral attachment, E1’s β-sheet structure and class II viral glycoproteins: DI, DII and DIII domains enable the virus to fuse with the host’s membrane. This primarily occurs through the insertion of the DII domain’s fusion loop into the host’s cell membrane.Together E1 and E2 form a viral spike protein which when binding with high affinity to host alphavirus receptors such as Mxra8, allow this receptor to be inserted into E1 and E2. This results in Mxra8 contact between E2’s A and B domains and E1’s fusion loop. Neutralizing antibodies can target these domains, in particular A and B domains within E2, hence preventing viral attachment to host cells. This recombinant antigen can be used in the development of diagnostic assays to detect the presence of the Chikungunya virus.

Propriétés chimiques

• Degré de pureté: ≥95% On 12.5% By Sds-Page. Single Band Visible At Approximately 50 Kda.